Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen

MA Villetti, AR Clementino, I Dotti, PR Ebani, E Quarta… - Molecules, 2021 - mdpi.com
Tamoxifen citrate (TMC), a non-steroidal antiestrogen drug used for the treatment of breast
cancer, was loaded in a block copolymer of maltoheptaose-b-polystyrene (MH-b-PS) …

Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo

NR Ravikumara, M Bharadwaj… - Journal of …, 2016 - journals.sagepub.com
The optimization of tamoxifen citrate entrapment and its release from biodegradable poly (d,
l) lactic acid nanoparticles are prepared by modified spontaneous emulsification solvent …

Chitosan-stearic acid based polymeric micelles for the effective delivery of tamoxifen: cytotoxic and pharmacokinetic evaluation

N Thotakura, M Dadarwal, P Kumar, G Sharma… - Aaps Pharmscitech, 2017 - Springer
Chitosan is a widely employed polysaccharide with positive zeta-potential and better
tissue/cell adhesion. Its hydrophilicity, high viscosity, and insolubility at physiological pH are …

Chitosan nanoparticles for tamoxifen delivery and cytotoxicity to MCF-7 and Vero cells

NR Ravikumara, B Madhusudhan - Pure and Applied Chemistry, 2011 - degruyter.com
In this study, tamoxifen citrate-loaded chitosan nanoparticles (tamoxcL-ChtNPs) and
tamoxifen citrate-free chitosan nanoparticles (tamoxcF-ChtNPs) were prepared by an ionic …

Chitosan-palmitic acid based polymeric micelles as promising carrier for circumventing pharmacokinetic and drug delivery concerns of tamoxifen

N Thotakura, M Dadarwal, R Kumar, B Singh… - International journal of …, 2017 - Elsevier
Being a BCS class II drug and a good substrate for microsomal enzymes, tamoxifen (TAM)
offers a scope for research owing to poor aqueous solubility and compromised …

Enhanced preclinical efficacy of tamoxifen developed as alginate–cysteine/disulfide bond reduced albumin nanoparticles

A Martinez, E Muniz, I Iglesias, JM Teijon… - International journal of …, 2012 - Elsevier
Tamoxifen (TMX) is the most common clinical choice for the treatment of advanced or
metastatic estrogen-dependent breast cancer. However, research on new challenging …

Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles

S Mazumdar, KS Italiya, S Sharma, D Chitkara… - International Journal of …, 2018 - Elsevier
The present study aims at the development of cholesterol based lipopolymeric nanoparticles
for improved entrapment, better cell penetration and improved pharmacokinetics of …

Non-covalently coated biopolymeric nanoparticles for improved tamoxifen delivery

MT Chevalier, N Rescignano, S Martin-Saldaña… - European polymer …, 2017 - Elsevier
About one-fifth of cancer patients suffer from breast cancer worldwide. Polymeric
nanoparticles play an important role in delivering chemotherapeutic agents in a controlled …

Actively targeted delivery of tamoxifen through stimuli-responsive polymeric nanoparticles for cancer chemotherapy

N Azimijou, R Karimi-Soflou, A Karkhaneh - Journal of Drug Delivery …, 2023 - Elsevier
Cancer has been one of the main healthcare problems, demanding novel therapeutic
approaches to improve treatment efficiency. Chemotherapy is a primary clinical therapeutic …

Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems

E Pérez, M Benito, C Teijon, R Olmo… - Journal of …, 2012 - Taylor & Francis
Nanoparticles (NP) from mixtures of two poly (d, l-lactide-co-caprolactone)(PLC)
copolymers, PLC 40/60 and PLC 86/14, with poly (d, l-lactide)(PDLLA) and PCL were …